Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  Neuroendocrine carcinoma
Stage/Subtype:  thyroid gland medullary carcinoma
Trial Type:  Treatment
Results 1-5 of 5 for your search:
Start Over
Pasireotide and Everolimus in Treating Patients with Thyroid Cancer Refractory to Radioiodine
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: WCI1777-09, NCI-2011-03377, CSOM230CUS18T, IRB00041909, WCI-1777, NCT01270321
Pazopanib Hydrochloride in Treating Patients with Progressive Carcinoid Tumors
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: A021202, NCI-2013-00831, ALLIANCE A021202, CALGB-A021202, NCT01841736
Vaccine Therapy in Treating Patients with Recurrent or Metastatic Medullary Thyroid Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 13-C-0095, NCI-2013-01587, GI-6207, GI-6207-02, P11934, NCT01856920
Liposomal Irinotecan and Veliparib in Treating Patients with Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 9914, NCI-2015-02125, NCT02631733
Effect of Cabozantinib S-Malate or Lenvatinib Mesylate on Weight and Body Composition in Patients with Metastatic Endocrine Cancer
Phase: No phase specified
Type: Supportive care, Treatment
Age: 18 and over
Trial IDs: 2014-0864, NCI-2015-02058, NCT02592356
Start Over